scispace - formally typeset
S

Srikanth Tripathy

Researcher at Indian Council of Medical Research

Publications -  167
Citations -  3472

Srikanth Tripathy is an academic researcher from Indian Council of Medical Research. The author has contributed to research in topics: Tuberculosis & Drug resistance. The author has an hindex of 27, co-authored 166 publications receiving 2678 citations. Previous affiliations of Srikanth Tripathy include University of Tokushima.

Papers
More filters
Journal ArticleDOI

Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: A systematic analysis from the Global Burden of Disease Study 2016

Nancy Fullman, +868 more
- 02 Jun 2018 - 
TL;DR: The pace of progress achieved between 1990 and 2016 varied, with markedly faster improvements occurring between 2000 and 2016 for many countries in sub-Saharan Africa and southeast Asia, whereas several countries in Latin America and elsewhere saw progress stagnate after experiencing considerable advances in the HAQ Index between1990 and 2000.
Journal ArticleDOI

Ivermectin for the treatment of Wuchereria bancrofti filariasis. Efficacy and adverse reactions.

TL;DR: Ivermectin treatment was evaluated for efficacy and side effects in 40 patients in South India who had microfilaremia and bancroftian filariasis, and it was found to be completely effective in clearing blood microfilariae within five to 12 days.
Journal ArticleDOI

Subnational mapping of under-5 and neonatal mortality trends in India: the Global Burden of Disease Study 2000–17

TL;DR: A detailed analysis of subnational trends of child mortality to inform efforts aimed at meeting the India National Health Policy (NHP) and Sustainable Development Goal (SDG) targets for child mortality is presented.
Journal ArticleDOI

Short course chemotherapy for tuberculous lymphadenitis in children.

TL;DR: Tuberculous lymphadenitis in children can be successfully treated with a short course chemotherapy regimen of six months, well tolerated and compliance was good.